Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Antibacterial Effects of Zno Nanoparticles on Patients with Urinary Tract Infection Isolated From Alzahra Hospital in Isfahan, Iran

Ladan Rahimzadeh Torabi 1 , *
Author Information
1 Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: November 2017, 19 (11); e10359
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: January 8, 2017
  • Revised: August 20, 2017
  • Accepted: October 14, 2017
  • DOI: 10.5812/zjrms.10359

To Cite: Rahimzadeh Torabi L. The Antibacterial Effects of Zno Nanoparticles on Patients with Urinary Tract Infection Isolated From Alzahra Hospital in Isfahan, Iran, Zahedan J Res Med Sci. 2017 ; 19(11):e10359. doi: 10.5812/zjrms.10359.

Abstract
Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012; 380(9857): 1927-35[DOI][PubMed]
  • 2. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008; (2)[DOI][PubMed]
  • 3. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001; 345(14): 1007-13[DOI][PubMed]
  • 4. Subashchandrabose S, Hazen TH, Rasko DA, Mobley HL. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates. Pathog Dis. 2013; 69(1): 66-70[DOI][PubMed]
  • 5. Hamid FR, Tajik AR, Noorifard M, Keshavarz A, Taghipour N, Hossieni SJ. Antibiotic resistance pattern of E. coli isolated from urine culture in 660 Army clinical laboratory center in Tehran 2008. Ann Mil Health Sci Res. 2008; 10(1): 45-9
  • 6. Mokhtarian D, Ghahramani M, Nourzad H. A study of antibiotic resistance of Escherichia coli isolated from urinary tract infection. Horizon Med Sci. 2006; 12(3): 5-10
  • 7. Barber AE, Norton JP, Spivak AM, Mulvey MA. Urinary tract infections: current and emerging management strategies. Clin Infect Dis. 2013; 57(5): 719-24[DOI][PubMed]
  • 8. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7(12): 653-60[DOI][PubMed]
  • 9. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med. 2011; 171(14): 1270-8[DOI][PubMed]
  • 10. Lichtenberger P, Hooton TM. Antimicrobial prophylaxis in women with recurrent urinary tract infections. Int J Antimicrob Agents. 2011; 38 Suppl: 36-41[DOI][PubMed]
  • 11. Moreno E, Andreu A, Perez T, Sabate M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect. 2006; 134(5): 1015-23[DOI][PubMed]
  • 12. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog. 2010; 6(11)[DOI][PubMed]
  • 13. van den Bogaard AE, London N, Driessen C, Stobberingh EE. Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother. 2001; 47(6): 763-71[PubMed]
  • 14. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in jimma university specialized hospital, southwest ethiopia. Ethiop J Health Sci. 2011; 21(2): 141-6[PubMed]
  • 15. Witte W. International dissemination of antibiotic resistant strains of bacterial pathogens. Infect Genet Evol. 2004; 4(3): 187-91[DOI][PubMed]
  • 16. Xia Y. Nanomaterials at work in biomedical research. Nat Mater. 2008; 7(10): 758-60[DOI][PubMed]
  • 17. Khan AU. Medicine at nanoscale: a new horizon. Int J Nanomedicine. 2012; 7: 2997-8[DOI][PubMed]
  • 18. Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol. 2007; 2: 16[DOI][PubMed]
  • 19. Dodd AC, McKinley AJ, Saunders M, Tsuzuki T. Effect of Particle Size on the Photocatalytic Activity of Nanoparticulate Zinc Oxide. J Nanoparticle Res. 2006; 8(1): 43-51[DOI]
  • 20. Yamamoto O. Influence of particle size on the antibacterial activity of zinc oxide. Int J Inorgan Mater. 2001; 3(7): 643-6[DOI]
  • 21. McCarthy TJ, Zeelie JJ, Krause DJ. The antimicrobial action of zinc ion/antioxidant combinations. J Clin Pharm Ther. 1992; 17(1): 51-4[PubMed]
  • 22. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic diseases in America Project: analytical methods and principal findings. J Urol. 2005; 173(3): 933-7[DOI][PubMed]
  • 23. Wang Z, Lee YH, Wu B, Horst A, Kang Y, Tang YJ, et al. Anti-microbial activities of aerosolized transition metal oxide nanoparticles. Chemosphere. 2010; 80(5): 525-9[DOI][PubMed]
  • 24. Baek YW, An YJ. Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ. 2011; 409(8): 1603-8[DOI]
  • 25. Zhang L, Jiang Y, Ding Y, Povey M, York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanoparticle Res. 2006; 9(3): 479-89[DOI]
  • 26. Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett. 2007; 90(213902): 2139021-3[DOI][PubMed]
  • 27. Jones N, Ray B, Ranjit KT, Manna AC. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett. 2008; 279(1): 71-6[DOI][PubMed]
  • 28. Nair S, Sasidharan A, Divya Rani VV, Menon D, Nair S, Manzoor K, et al. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med. 2009; 20 Suppl 1-41[DOI][PubMed]
  • 29. Padmavathy N, Vijayaraghavan R. Enhanced bioactivity of ZnO nanoparticles—an antimicrobial study. Sci Technol Adv Mater. 2008; 9(3): 35004
  • 30. Liu Y, He L, Mustapha A, Li H, Hu ZQ, Lin M. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157: H7. J Appl Microbiol. 2009; 107(4): 1193-201
  • 31. Arabi F, Imandar M, Negahdary M, Imandar M, Noughabi MT, Akbari-dastjerdi H, et al. Investigation anti-bacterial effect of zinc oxide nanoparticles upon life of Listeria monocytogenes. Ann Biol Res. 2012; 7: 3679-85
  • 32. Wahab R, Mishra A, Yun S, Kim YS, Shin HS. Antibacterial activity of ZnO nanoparticles prepared via non-hydrolytic solution route. Appl Microbiol Biotechnol. 2010; 87(5): 1917-25[DOI]
  • 33. Sirelkhatim A, Mahmud S, Seeni A, Kaus NH, Ann LC, Bakhori SKM, et al. Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism. Nano-Micro Lett. 2015; 7(3): 219-42[DOI]
  • 34. Ghaderian HS, Mohammadi Sichani M, Yousefi MH. Antibacterial Activity of ZnO Nanoparticles and Filters Coated with ZnO Nanoparticles on Eliminating Escherichia coli and Enterococcus faecalis. Wastewater J Iran. 2015; 8(2): 36-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments